{Reference Type}: Journal Article
{Title}: Transcription Factor Zbtb20 as a Regulator of Malignancy and Its Practical Applications.
{Author}: Stoyanov D;Stoyanov GS;Ivanov MN;Spasov RH;Tonchev AB;
{Journal}: Int J Mol Sci
{Volume}: 24
{Issue}: 18
{Year}: 2023 Sep 6
{Factor}: 6.208
{DOI}: 10.3390/ijms241813763
{Abstract}: Zbtb20 (zinc finger and BTB domain-containing protein 20) is a transcription factor with a zinc finger DNA binding domain and a BTB domain responsible for protein-protein interaction. Recently, this TF has received attention because new data showed its pivotal involvement in normal neural development and its regulatory effects on proliferation and differentiation in different tissues. Zbtb20 was shown to increase proliferation and migration and confer resistance to apoptosis in the contexts of many malignant tumors like hepatocellular carcinoma, non-small-cell lung carcinoma, gastric adenocarcinoma, glioblastoma multiforme, breast cancer, and acute myeloid leukemia. The involvement of Zbtb20 in tumor biology is best studied in hepatocellular carcinoma, where it is a promising candidate as an immunohistochemical tumor marker or may be used in patient screening. Here we review the current data connecting Zbtb20 with malignant tumors.